Sinovac Biotech Ltd. (NASDAQ:SVA)

CAPS Rating: 2 out of 5

A biopharmaceutical company which is in the business of research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases.

Recs

0
Player Avatar BuffettJunior1 (97.53) Submitted: 10/28/2011 3:37:25 PM : Underperform Start Price: $2.05 SVA Score: +16.35

Chinese reverse merger fraud.

Featured Broker Partners


Advertisement